# Evaluate the Benefit of an Individualised Treatment Plan (VitalCare) VS SOC in OSA Patients Treated With CPAP/APAP

> **NCT05246449** · NA · COMPLETED · sponsor: **Air Liquide Santé International** · enrollment: 113 (actual)

## Conditions studied

- Obstructive Sleep Apnoea Syndrome (OSAS)

## Interventions

- **OTHER:** individualised treatment plan (VitalCare) and associated remote medical monitoring

## Key facts

- **NCT ID:** NCT05246449
- **Lead sponsor:** Air Liquide Santé International
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-15
- **Primary completion:** 2023-02-15
- **Final completion:** 2024-06-30
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2025-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05246449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05246449, "Evaluate the Benefit of an Individualised Treatment Plan (VitalCare) VS SOC in OSA Patients Treated With CPAP/APAP". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05246449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*